RJ Reynolds Vapor Company plans to challenge the US Food and Drug Administration (FDA)’s rejection of its Vuse menthol vape cartridges, joining a judicial fight that has had mixed results for other companies.
Reynolds will ask an appeals court to stay the FDA’s decision to deny two pre-market tobacco product applications (PMTAs) submitted for the company’s Vuse Vibe Tank Menthol 3% and its Vuse Ciro Cartridge Menthol 1.5%. The promised legal challenge comes amid conflicting opinions about the FDA’s rejection of Reynolds’s PMTAs and a legal landscape that has seen some companies win and others lose.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
LATEST ALERTS
